Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Tedeschi, A
  • Ahn, IE
  • Fraser, Graeme
  • Greil, R
  • Munir, T
  • Kay, NE
  • Flinn, IW
  • Lee, S
  • Saifan, C
  • Kearbey, J
  • Patel, S
  • Barrientos, JC

publication date

  • June 2023